
Chemists' body complains to check unregulated advertisement campaigns by online medicine sellers on social media
In a representation submitted to the CCI chairperson Ravneet Kaur on July 3, the chemists body has said such advertising campaigns mislead consumers and exploit emotions while promoting irrational medicine use. Such campaigns also undermine regulated pharmacy practice - fueling antimicrobial resistance and endangering public health, the representation stated.
'The CCI should take suo motu cognizance of the grave and growing menace posed by unregulated pharmaceutical advertisements, deceptive discounting strategies, and algorithm-driven predatory pricing on social media and digital platforms. These practices are not merely anti-competitive - they represent a direct assault on public health, patient safety, and ethical pharmacy practice across our nation,' the representation stated.
Legal investigation
'We appeal to the CCI chairperson to conduct a detailed legal investigation into the functioning, algorithms, and pricing models of unregulated digital medicine sellers and retail chains of medical stores and their affiliated advertising networks,' BDCDA president B. Thirunavukkarasu told The Hindu on Friday.
Pointing out that licensed pharmacists are professionally trained health custodians, he said their roles must not be undermined by 'algorithmic advertisements and discount-hunting psychology' engineered by tech platforms. 'Each manipulated advertisement damages not just reputations, but real lives,' he asserted.
'We want the CCI to set up a dedicated 'Social Media and Digital Platform Monitoring Cell' to check the unregulated advertisement campaigns on social media. The cell should comprise representatives from Narcotics Control Bureau, Indian Cyber Crime Coordination Centre, Department of Consumer Affairs, National Pharmaceutical Pricing Authority, Central Drugs Standard Control Organization (CDSCO), Advertising Standards Council of India (ASCI), State Food Safety and Drug Administration and Pharmacy Council of India (PCI),' he said.
Real-time surveillance
'This cell should be empowered with real-time surveillance, penal enforcement powers, and regulatory oversight capabilities to combat and dismantle what now amounts to 'National Public Health Terrorism' - where commercial digital platforms, for profit, are compromising the very sanctity of ethical healthcare delivery,' he asserted.
Demanding that legal proceedings be initiated and interim restraint orders be issued against the violators, Mr. Thirunavukkarasu said: 'The CCI should recommend or direct the immediate suspension of advertisement campaigns involving Schedule H/H1 medicines lacking proper prescription safeguards. It should also mandate the enforcement of standardised public health disclaimers across all digital medicine-related advertisements.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
2 days ago
- Time of India
Publicis sues India antitrust body for denying case files in ad agencies probe
Publicis has sued India's antitrust watchdog for denying access to case files in a high-profile price-fixing investigation of ad agencies, after the French group failed to get the probe stalled until it could review the documents, court filings show. Independence Day 2025 Before Trump, British used tariffs to kill Indian textile Bank of Azad Hind: When Netaji gave India its own currency Swadeshi 2.0: India is no longer just a market, it's a maker The Competition Commission of India (CCI) shook India's near-$30 billion media and entertainment sector in March with dawn raids at WPP's GroupM, Dentsu, Publicis , Omnicom and many other agencies over suspected collusion over publicity rates and discounts. Details of cartel cases are kept confidential in India, but Reuters has reported that the CCI's initial assessment found the firms used a WhatsApp group to coordinate and agree on pricing, entered into secret pacts, and colluded with broadcasters to deny business to agencies that didn't comply. Concerned the CCI has not responded to its requests in recent months to provide access to case files, Publicis approached the Delhi High Court on August 11 asking judges to order the watchdog to accede to its requests, according to its non-public filing reviewed by Reuters on Thursday. Publicis and its employees in India are "unable to understand the allegations against them and prepare a defence in the absence of the case records", it said in the filing. Live Events The CCI did not respond to Reuters queries, and the court is likely to hear Publicis' case next week. The filing was made by TLG India, which its court papers said "is the legal entity that houses majority of the advertising business of the Publicis group in India". The antitrust investigation was triggered by Dentsu disclosing alleged industry malpractices to the CCI in February 2024 under the regulator's leniency program, which allows lesser penalties for firms that share evidence of malpractice. Publicis is the first company to file a lawsuit related to the high-profile CCI investigation in court. Filings showed the company urged the CCI in July that "further investigation remain in abeyance till" it is granted inspection of case records. CCI investigations typically take several months. The regulator has powers to impose financial penalties on the media agencies of up to three times their profit or 10% of an Indian entity's global turnover, whichever is higher, for each year of wrongdoing. Publicis' court filing also showed the CCI in July asked for a brief note from the company about its business model, and how operations are coordinated with the parent entity. On August 4, the CCI issued summons to Publicis' South Asia chief Anupriya Acharya to appear before investigators, and provide documents such as copies of key contracts involving Publicis and its Indian entities, including on revenue sharing. Acharya did not respond to Reuters queries, and Publicis has asked the court to quash the summon.
&w=3840&q=100)

Business Standard
3 days ago
- Business Standard
FedEx, UPS, DHL executives may face fresh scrutiny in antitrust case
Top India executives of FedEx, UPS, Aramex and DHL are set to be cross-examined in coming weeks by a book publishers' group which accused them of price collusion, a new twist in an antitrust probe that cleared the courier companies of wrongdoing last year, a document shows. Allowing a complainant to interrogate companies is not common in Indian antitrust cases. It means the final findings of the antitrust investigation could change and create new challenges for the courier majors, and the case will be prolonged by several months, antitrust lawyers and government sources said. Many foreign and domestic companies are bullish about the Indian courier and parcel delivery market, which is expected to grow 11 per cent a year to $14.3 billion by 2030, bolstered by a boom in online shopping, research firm Mordor Intelligence says. In December, Reuters reported the Competition Commission of India (CCI) found "no evidence" of courier firms sharing commercial information amongst themselves. The 2022 cartel case, whose details remain confidential in line with rules, was triggered when the Federation of Indian Publishers alleged collusion on prices and discounts by delivery firms. The CCI has now found merit in a complaint by the publishers' group which argued it must be allowed to cross-examine the delivery company executives as investigators only relied on oral submissions to give the companies a clean chit. The federation "has demonstrated sufficient cause establishing necessity and expediency of conducting such cross-examination," the CCI noted in a May 28 internal order that was reviewed by Reuters. The order said the executives to be questioned were Subhasish Chakraborty, Managing Director of India's DTDC Express; R.S. Subramanian, Managing Director of DHL Express India; Suvendu Choudhury, a vice president of FedEx in India; Percy Avari, general manager of Aramex in India, and Abbas Panju, India managing director of UPS Express. None of the executives responded to requests for comment. DHL said in a statement it operates in full compliance with all laws and is "cooperating fully with the CCI", but could not comment on specifics. The CCI, as well as other companies - DTDC, U.S.-based FedEx and UPS, and Dubai's Aramex did not respond to Reuters queries. The Federation of Indian Publishers also did not respond. It represents many Indian publishers like and Rupa Publications, as well as some foreign groups like Pan Macmillan. 'RARE' CROSS-EXAMINATION Sending the case back to the CCI investigators could become an irritant for the logistics industry, which has faced scrutiny since 2015, when France levied a $735 million fine on 20 companies, including FedEx and DHL, for secretly colluding to increase prices. In India, cross-examination of companies by the complainant "is rare," said Gautam Shahi, a competition law partner at Indian law firm Dua Associates. "Such cross-examination may reveal new facts and the conclusions of the earlier investigation report may come into question. It may change the direction of the case," he said. The CCI investigations unit will now oversee the cross-examination proceedings in coming weeks and submit a report to top antitrust officials for a review, four sources familiar with the matter said. The Federation of Indian Publishers had alleged that courier companies acted together to determine charges, and also did not reduce the fuel surcharge they charged when jet fuel prices dropped. The 202-page investigation report shared with the companies privately last year, and seen by Reuters this week, notes that 36 notices were sent to 15 courier firms during 2023-24 to gather details of their businesses, with UPS submitting the most responses - 13. The CCI report concludes no email correspondence surfaced that showed "any collusive/concerted activities" among rivals. The Federation of Indian Publishers has also successfully argued it wants to point out several anomalies in the earlier recorded statements of company executives, which were ignored by investigators, noted the CCI order that allowed the cross-examination.
&w=3840&q=100)

Business Standard
3 days ago
- Business Standard
Publicis sues CCI for denying case files in ad firms' cartelisation probe
Publicis has sued India's antitrust watchdog for denying access to case files in a high-profile price-fixing investigation of ad agencies, after the French group failed to get the probe stalled until it could review the documents, court filings show. The Competition Commission of India (CCI) shook India's near-$30 billion media and entertainment sector in March with dawn raids at WPP's GroupM, Dentsu, Publicis, Omnicom and many other agencies over suspected collusion over publicity rates and discounts. Details of cartel cases are kept confidential in India, but Reuters has reported that the CCI's initial assessment found the firms used a WhatsApp group to coordinate and agree on pricing, entered into secret pacts, and colluded with broadcasters to deny business to agencies that didn't comply. Concerned the CCI has not responded to its requests in recent months to provide access to case files, Publicis approached the Delhi High Court on August 11 asking judges to order the watchdog to accede to its requests, according to its non-public filing reviewed by Reuters on Thursday. Publicis and its employees in India are "unable to understand the allegations against them and prepare a defence in the absence of the case records", it said in the filing. The CCI did not respond to Reuters queries, and the court is likely to hear Publicis' case next week. The filing was made by TLG India, which its court papers said "is the legal entity that houses majority of the advertising business of the Publicis group in India". The antitrust investigation was triggered by Dentsu disclosing alleged industry malpractices to the CCI in February 2024 under the regulator's leniency program, which allows lesser penalties for firms that share evidence of malpractice. Publicis is the first company to file a lawsuit related to the high-profile CCI investigation in court. Filings showed the company urged the CCI in July that "further investigation remain in abeyance till" it is granted inspection of case records. CCI investigations typically take several months. The regulator has powers to impose financial penalties on the media agencies of up to three times their profit or 10 per cent of an Indian entity's global turnover, whichever is higher, for each year of wrongdoing. Publicis' court filing also showed the CCI in July asked for a brief note from the company about its business model, and how operations are coordinated with the parent entity. On August 4, the CCI issued summons to Publicis' South Asia chief Anupriya Acharya to appear before investigators, and provide documents such as copies of key contracts involving Publicis and its Indian entities, including on revenue sharing. Acharya did not respond to Reuters queries, and Publicis has asked the court to quash the summon.